Matthew Charman
Impact in
-
- Virus-based gene therapy research
Papers in
-
- RNA Research and Splicing 5
- RNA modifications and cancer 2
- Bacterial biofilms and quorum sensing 1
- Genetics 7
- Virus-based gene therapy research 7
- Co-authors
- Matthew D. Weitzman (9 shared papers)Christin Herrmann (2 shared papers)Joseph M. Dybas (3 shared papers)Kristen L. Conn (1 shared paper)Steven McFarlane (2 shared papers)Chris Boutell (2 shared papers)Richard Lauman (4 shared papers)L. Tong (1 shared paper)
- Journals
- Journal of Virology (2 papers)Frontiers in Cellular and Infection Microbiology (1 paper)PLoS Pathogens (1 paper)The EMBO Journal (1 paper)FEBS Letters (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Matthew Charman
12 papers receiving 287 citations
Peers
Comparison fields: 5 of 50
- Genetics 119
- Endocrinology 15
- Molecular Medicine 13
- Immunology 54
- Molecular Biology 166
Countries citing papers authored by Matthew Charman
This map shows the geographic impact of Matthew Charman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Charman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Charman more than expected).
Fields of papers citing papers by Matthew Charman
This network shows the impact of papers produced by Matthew Charman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Charman. The network helps show where Matthew Charman may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Charman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 59 | |
| 2 | 2016 | 44 | |
| 3 | 2020 | 43 | |
| 4 | 2023 | 29 | |
| 5 | 2020 | 28 | |
| 6 | 2013 | 17 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2015 | 13 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2025 | 0 |
About Matthew Charman
Matthew Charman is a scholar working on Molecular Biology, Genetics, Ecology, Immunology and Animal Science and Zoology, having authored 13 papers that have together received 288 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), RNA Research and Splicing (5 papers), interferon and immune responses (4 papers), Bacteriophages and microbial interactions (4 papers), Animal Virus Infections Studies (2 papers), RNA modifications and cancer (2 papers), Atmospheric aerosols and clouds (1 paper) and Bacterial biofilms and quorum sensing (1 paper). The work is most often cited by research in Genetics (119 citations), Endocrinology (15 citations), Molecular Medicine (13 citations), Immunology (54 citations) and Molecular Biology (166 citations). Matthew Charman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Matthew D. Weitzman, Christin Herrmann, Joseph M. Dybas, Kristen L. Conn, Steven McFarlane, Chris Boutell, Richard Lauman, L. Tong, James R. Brown and Alexander M. Price. Their work appears in journals such as Journal of Virology, Frontiers in Cellular and Infection Microbiology, PLoS Pathogens, The EMBO Journal and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.